日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity

AT13148 是一种新型口服多 AGC 激酶抑制剂,具有强效药效学和抗肿瘤活性

Timothy A Yap, Mike I Walton, Kyla M Grimshaw, Robert H Te Poele, Paul D Eve, Melanie R Valenti, Alexis K de Haven Brandon, Vanessa Martins, Anna Zetterlund, Simon P Heaton, Kathrin Heinzmann, Paul S Jones, Ruth E Feltell, Matthias Reule, Steven J Woodhead, Thomas G Davies, John F Lyons, Florence I

AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth

AT7867 是一种强效口服 AKT 和 p70 S6 激酶抑制剂,可诱导药效学变化并抑制人类肿瘤异种移植生长

Kyla M Grimshaw, Lisa-Jane K Hunter, Timothy A Yap, Simon P Heaton, Mike I Walton, Steven J Woodhead, Lynsey Fazal, Matthias Reule, Thomas G Davies, Lisa C Seavers, Victoria Lock, John F Lyons, Neil T Thompson, Paul Workman, Michelle D Garrett